Tissue engineering and regenerative medicine -where do we stand

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 6, 2012, Pages 1157-1165

  Horch, Raymund E ^a   Kneser, Ulrich ^a   Polykandriotis, Elias ^a   Schmidt, Volker J ^a   Sun, Jiaming ^b   Arkudas, Andreas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; AV loop; Cell transplantation; Embryonal stem cells; Gene transfer; Mesenchymal stem cells; Regenerative medicine; Telocytes; Tissue engineering; Vascularization

Indexed keywords

ADULT STEM CELL; ANIMAL; ARTICLE; GENE THERAPY; GENE TRANSFER; HUMAN; MESENCHYMAL STEM CELL; METHODOLOGY; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TRANSLATIONAL RESEARCH;

ADULT STEM CELLS; ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MESENCHYMAL STEM CELLS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84861538254     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01564.x     Document Type: Article

References (108)

1. Langer R, Vacanti JP. Tissue engineering. Science. 1993; 260: 920-6.
2. Vacanti CA. History of tissue engineering and a glimpse into its future. Tissue Eng. 2006; 12: 1137-42.
3. Atala A. Bioengineered tissues for urogenital repair in children. Pediatr Res. 2008; 63: 569-75.
4. Bleiziffer O, Hammon M, Naschberger E, et al. Endothelial progenitor cells are integrated in newly formed capillaries and alter adjacent fibrovascular tissue after subcutaneous implantation in a fibrin matrix. J Cell Mol Med. 2011; 15: 2452-61.
5. Polykandriotis E, Drakotos D, Arkudas A, et al. Factors influencing successful outcome in the arteriovenous loop model: a retrospective study of 612 loop operations. J Reconstr Microsurg. 2011; 27: 11-8.
6. Beier JP, Hess A, Loew J, et al. De novo generation of an axially vascularized processed bovine cancellous-bone substitute in the sheep arteriovenous-loop model. Eur Surg Res. 2011; 46: 148-55.
7. Atala A. Human embryonic stem cells: early hints on safety and efficacy. Lancet. 2012; 379: 689-90.
8. Polykandriotis E, Popescu LM, Horch RE. Regenerative medicine: then and now-an update of recent history into future possibilities. J Cell Mol Med. 2010; 14: 2350-8.
9. Xu RH, Peck RM, Li DS, et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005; 2: 185-90.
10. Arkudas A, Beier JP, Pryymachuk G, et al. Automatic quantitative micro-computed tomography evaluation of angiogenesis in an axially vascularized tissue-engineered bone construct. Tissue Eng Part C Methods. 2010; 16: 1503-14.
11. Roemeling-van Rhijn M, Weimar W, Hoogduijn MJ. Mesenchymal stem cells: application for solid-organ transplantation. Curr Opin Organ Transplant. 2012; 17: 55-62.
12. Cossetti C, Alfaro-Cervello C, Donega M, et al. New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies. Cell Tissue Res. 2012; in press: doi: 10.1007/s00441-012-1341-8.
13. Mistry AS, Pham QP, Schouten C, et al. In vivo bone biocompatibility and degradation of porous fumarate-based polymer/alumoxane nanocomposites for bone tissue engineering. J Biomed Mater Res A. 2010; 92: 451-62.
14. Jin G, Prabhakaran MP, Nadappuram BP, et al. Electrospun Poly(l-Lactic Acid)-co-Poly(varepsilon-Caprolactone) Nanofibres Containing Silver Nanoparticles for Skin-Tissue Engineering. J Biomater Sci Polym Ed. 2012; in press: doi: jbs3388 [pii] 10.1163/156856211X617399.
15. Liu T, Houle JD, Xu J, et al. Nanofibrous Collagen Nerve Conduits for Spinal Cord Repair. Tissue Eng Part A. 2012; in press: doi: 10.1089/ten.TEA.2011.0430.
16. Suri S, Han LH, Zhang W, et al. Solid freeform fabrication of designer scaffolds of hyaluronic acid for nerve tissue engineering. Biomed Microdevices. 2011; 13: 983-93.
17. Trimborn M, Endres M, Bommer C, et al. Karyotyping of human chondrocytes in scaffold-assisted cartilage tissue engineering. Acta Biomater. 2011; 8: 1519-29.
18. Silva GA, Silva NF, Fortunato TM. Stem cell and tissue engineering therapies for ocular regeneration. Curr Stem Cell Res Ther. 2011; 6: 255-72.
19. Wong ML, Leach JK, Athanasiou KA, Griffiths LG. The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering. Biomaterials. 2011; 32: 8129-38.
20. Kollhoff DM, Cheng EY, Sharma AK. Urologic applications of engineered tissue. Regen Med. 2011; 6: 757-65.
21. Atala A. Regenerative medicine strategies. J Pediatr Surg. 2012; 47: 17-28.
22. Cassell OC, Hofer SO, Morrison WA, Knight KR. Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plast Surg. 2002; 55: 603-10.
23. Arkudas A, Beier JP, Heidner K, et al. Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. Tissue Eng. 2007; 13: 1549-60.
24. Arkudas A, Tjiawi J, Bleiziffer O, et al. Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model. Mol Med. 2007; 13: 480-7.
25. Arkudas A, Pryymachuk G, Hoereth T, et al. Dose-finding study of fibrin gel-immobilized vascular endothelial growth factor 165 and basic fibroblast growth factor in the arteriovenous loop rat model. Tissue Eng Part A. 2009; 15: 2501-11.
26. Kneser U, Polykandriotis E, Ohnolz J, et al. Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng. 2006; 12: 1721-31.
27. Erol OO, Spira M. New capillary bed formation with a surgically constructed arteriovenous fistula. Surg Forum. 1979; 30: 530-1.
28. Mian R, Morrison WA, Hurley JV, et al. Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Eng. 2000; 6: 595-603.
29. Lokmic Z, Stillaert F, Morrison WA, et al. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. Faseb J. 2007; 21: 511-22.
30. Polykandriotis E, Horch RE, Arkudas A, et al. Intrinsic versus extrinsic vascularization in tissue engineering. Adv Exp Med Biol. 2006; 585: 311-26.
31. Polykandriotis E, Tjiawi J, Euler S, et al. The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res. 2008; 75: 25-33.
32. Schipper J, Boedeker CC, Horch RE, et al. The free vastus lateralis flap for reconstruction in ablative oncologic head and neck surgery. Eur J Surg Oncol. 2006; 32: 103-7.
33. Horch RE, Schipper J, Laszig R. Retroauricular skin flap and primary Z-plasty for donor site closure in partial ear reconstruction. J Laryngol Otol. 2003; 117: 487-9.
34. Schipper J, Ridder GJ, Maier W, et al. Laryngotracheal reconstruction using prefabricated and preconditioned composite radial forearm free flaps. A report of two cases. Auris Nasus Larynx. 2007; 34: 253-8.
35. Garfein ES, Orgill DP, Pribaz JJ. Clinical applications of tissue engineered constructs. Clin Plast Surg. 2003; 30: 485-98.
36. Pribaz JJ, Fine N, Orgill DP. Flap prefabrication in the head and neck: a 10-year experience. Plast Reconstr Surg. 1999; 103: 808-20.
37. Pribaz JJ, Fine NA. Prelamination: defining the prefabricated flap-a case report and review. Microsurgery. 1994; 15: 618-23.
38. Horch RE. [The development of plastic surgery: retrospective view of 80 years of "Der Chirurg" (The Surgeon)]. Chirurg. 2009; 80: 1132-9.
39. Shen TY. Microvascular transplantation of prefabricated free thigh flap. Plast Reconstr Surg. 1982; 69: 568.
40. Hyakusoku H, Okubo M, Umeda T, Fumiiri M. A prefabricated hair-bearing island flap for lip reconstruction. Br J Plast Surg. 1987; 40: 37-9.
41. Hirase Y, Valauri FA, Buncke HJ. Neovascularized bone, muscle, and myo-osseous free flaps: an experimental model. J Reconstr Microsurg. 1988; 4: 209-15.
42. Hirase Y, Valauri FA, Buncke HJ, Newlin LY. Customized prefabricated neovascularized free flaps. Microsurgery. 1987; 8: 218-24.
43. Morrison WA, Dvir E, Doi K, et al. Prefabrication of thin transferable axial-pattern skin flaps: an experimental study in rabbits. Br J Plast Surg. 1990; 43: 645-54.
44. Khouri RK, Upton J, Shaw WW. Prefabrication of composite free flaps through staged microvascular transfer: an experimental and clinical study. Plast Reconstr Surg. 1991; 87: 108-15.
45. Polykandriotis E, Arkudas A, Euler S, et al. [Prevascularisation strategies in tissue engineering]. Handchir Mikrochir Plast Chir. 2006; 38: 217-23.
46. Polykandriotis E, Arkudas A, Horch RE, et al. Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science. J Cell Mol Med. 2007; 11: 6-20.
47. Hudlett P, Neuville A, Miternique A, et al. Angiogenesis and arteriogenesis are increased in fibrin gel chambers implanted in prehypertensive spontaneously hypertensive rats. J Hypertens. 2005; 23: 1559-64.
48. Jackson MR, MacPhee MJ, Drohan WN, Alving BM. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis. 1996; 7: 737-46.
49. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol. 1989; 109: 1-6.
50. Quirinia A, Viidik A. The effect of recombinant basic fibroblast growth factor (bFGF) in fibrin adhesive vehicle on the healing of ischaemic and normal incisional skin wounds. Scand J Plast Reconstr Surg Hand Surg. 1998; 32: 9-18.
51. Sahni A, Baker CA, Sporn LA, Francis CW. Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation. Thromb Haemost. 2000; 83: 736-41.
52. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood. 2000; 96: 3772-8.
53. Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem. 1998; 273: 7554-9.
54. van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci. 2001; 936: 426-37.
55. Wong C, Inman E, Spaethe R, Helgerson S. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost. 2003; 89: 573-82.
56. Ye Q, Zund G, Benedikt P, et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2000; 17: 587-91.
57. Arkudas A, Pryymachuk G, Beier JP, et al. Combination of extrinsic and intrinsic pathways significantly accelerates axial vascularization of bioartificial tissues. Plast Reconstr Surg. 2012; 129: 55e-65e.
58. Bleiziffer O, Eriksson E, Yao F, et al. Gene transfer strategies in tissue engineering. J Cell Mol Med. 2007; 11: 206-23.
59. Bleiziffer O, Horch RE, Hammon M, et al. T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix. J Cell Mol Med. 2009; 13: 926-35.
60. Roizman B. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci USA. 1996; 93: 11307-12.
61. Siemens DR, Austin JC, Hedican SP, et al. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model. J Natl Cancer Inst. 2000; 92: 403-12.
62. Chandler LA, Doukas J, Gonzalez AM, et al. FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Mol Ther. 2000; 2: 153-60.
63. Svensjo T, Yao F, Pomahac B, et al. Cultured autologous fibroblasts augment epidermal repair. Transplantation. 2002; 73: 1033-41.
64. Andree C, Voigt M, Wenger A, et al. Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Eng. 2001; 7: 757-66.
65. Yang KG, Saris DB, Geuze RE, et al. Impact of expansion and redifferentiation conditions on chondrogenic capacity of cultured chondrocytes. Tissue Eng. 2006; 12: 2435-47.
66. Lee RJ, Springer ML, Blanco-Bose WE, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation. 2000; 102: 898-901.
67. Vacanti JP, Morse MA, Saltzman WM, et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg. 1988; 23: 3-9.
68. Chandler LA, Gu DL, Ma C, et al. Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen. 2000; 8: 473-9.
69. Tyrone JW, Mogford JE, Chandler LA, et al. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J Surg Res. 2000; 93: 230-6.
70. Erdag G, Medalie DA, Rakhorst H, et al. FGF-7 expression enhances the performance of bioengineered skin. Mol Ther. 2004; 10: 76-85.
71. Berry M, Gonzalez AM, Clarke W, et al. Sustained effects of gene-activated matrices after CNS injury. Mol Cell Neurosci. 2001; 17: 706-16.
72. Lehrman S. Virus treatment questioned after gene therapy death. Nature. 1999; 401: 517-8.
73. Pannier AK, Shea LD. Controlled release systems for DNA delivery. Mol Ther. 2004; 10: 19-26.
74. Yao F, Theopold C, Hoeller D, et al. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector. Mol Ther. 2006; 13: 1133-41.
75. Vacanti CA. The history of tissue engineering. J Cell Mol Med. 2006; 10: 569-76.
76. Vacanti CA, Vacanti JP. The science of tissue engineering. Orthop Clin North Am. 2000; 31: 351-6.
77. Beier JP, Bitto FF, Lange C, et al. Myogenic differentiation of mesenchymal stem cells co-cultured with primary myoblasts. Cell Biol Int. 2011; 35: 397-406.
78. Boos AM, Loew JS, Deschler G, et al. Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model. J Cell Mol Med. 2011; 15: 1364-78.
79. Kneser U, Stangenberg L, Ohnolz J, et al. Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. J Cell Mol Med. 2006; 10: 695-707.
80. Fiegel HC, Pryymachuk G, Rath S, et al. Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat. J Cell Mol Med. 2010; 14: 267-74.
81. Bach AD, Arkudas A, Tjiawi J, et al. A new approach to tissue engineering of vascularized skeletal muscle. J Cell Mol Med. 2006; 10: 716-26.
82. Rath SN, Strobel LA, Arkudas A, et al. Osteoinduction and survival of osteoblasts and bone-marrow stromal cells in 3D biphasic calcium phosphate scaffolds under static and dynamic culture conditions. J Cell Mol Med. 2012; in press: doi: 10.1111/j.1582-4934.2012.01545.x.
83. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008; 14: 818-29.
84. Hutmacher DW, Horch RE, Loessner D, et al. Translating tissue engineering technology platforms into cancer research. J Cell Mol Med. 2009; 13: 1417-27.
85. Polykandriotis E, Euler S, Arkudas A, et al. Regression and persistence: remodelling in a tissue engineered axial vascular assembly. J Cell Mol Med. 2009; 13: 4166-75.
86. Popescu LM, Faussone-Pellegrini MS. TELOCYTES - a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010; 14: 729-40.
87. Kostin S. Myocardial telocytes: a specific new cellular entity. J Cell Mol Med. 2010; 14: 1917-21.
88. Suciu L, Nicolescu MI, Popescu LM. Cardiac telocytes: serial dynamic images in cell culture. J Cell Mol Med. 2010; 14: 2687-92.
89. Suciu L, Popescu LM, Gherghiceanu M, et al. Telocytes in human term placenta: morphology and phenotype. Cells Tissues Organs. 2010; 192: 325-39.
90. Cantarero Carmona I, Luesma Bartolome MJ, Junquera Escribano C. Identification of telocytes in the lamina propria of rat duodenum: transmission electron microscopy. J Cell Mol Med. 2011; 15: 26-30.
91. Zheng Y, Bai C, Wang X. Telocyte morphologies and potential roles in diseases. J Cell Physiol. 2012; 227: 2311-7.
92. Zheng Y, Li H, Manole CG, et al. Telocytes in trachea and lungs. J Cell Mol Med. 2011; 15: 2262-8.
93. Gherghiceanu M, Popescu LM. Heterocellular communication in the heart: electron tomography of telocyte-myocyte junctions. J Cell Mol Med. 2011; 15: 1005-11.
94. Gherghiceanu M, Popescu LM. Cardiac telocytes - their junctions and functional implications. Cell Tissue Res. 2012; in press: doi: 10.1007/s00441-012-1333-8.
95. Hinescu ME, Gherghiceanu M, Suciu L, Popescu LM. Telocytes in pleura: two- and three-dimensional imaging by transmission electron microscopy. Cell Tissue Res. 2011; 343: 389-97.
96. Gevaert T, De Vos R, Van Der Aa F, et al. Identification of telocytes in the upper lamina propria of the human urinary tract. J Cell Mol Med. 2011; in press: doi: 10.1111/j.1582-4934.2011.01504.x.
97. Popescu LM, Manole E, Serboiu CS, et al. Identification of telocytes in skeletal muscle interstitium: implication for muscle regeneration. J Cell Mol Med. 2011; 15: 1379-92.
98. Cantarero I, Luesma MJ, Junquera C. The primary cilium of telocytes in the vasculature: electron microscope imaging. J Cell Mol Med. 2011; 15: 2594-600.
99. Popescu LM, Gherghiceanu M, Suciu LC, et al. Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res. 2011; 345: 391-403.
100. Cismasiu VB, Radu E, Popescu LM. miR-193 expression differentiates telocytes from other stromal cells. J Cell Mol Med. 2011; 15: 1071-4.
101. Nicolescu MI, Bucur A, Dinca O, et al. Telocytes in Parotid Glands. Anat Rec (Hoboken). 2011; 295: 378-85.
102. Nicolescu MI, Popescu LM. Telocytes in the Interstitium of Human Exocrine Pancreas: ultrastructural Evidence. Pancreas. 2012; in press: doi: 10.1097/MPA.0b013e31823fbded.
103. Rusu MC, Jianu AM, Mirancea N, et al. Tracheal telocytes. J Cell Mol Med. 2012; 16: 401-5.
104. Popescu LM, Manole CG, Gherghiceanu M, et al. Telocytes in human epicardium. J Cell Mol Med. 2010; 14: 2085-93.
105. Gherghiceanu M, Manole CG, Popescu LM. Telocytes in endocardium: electron microscope evidence. J Cell Mol Med. 2010; 14: 2330-4.
106. Popescu LM, Gherghiceanu M, Manole CG, Faussone-Pellegrini MS. Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches. J Cell Mol Med. 2009; 13: 866-86.
107. Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images. J Cell Mol Med. 2010; 14: 871-7.
108. Manole CG, Cismasiu V, Gherghiceanu M, Popescu LM. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med. 2011; 15: 2284-96.